🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine if a new drug, RO4929097, can wor...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2010-09
Trial ID
NCT01198535
This phase I/II clinical trial is studying the side effects and best dose o...
Status
Terminated
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2010-03
Trial ID
NCT01088763
This phase II trial is studying how well RO4929097 (gamma-secretase/Notch s...
Status
Completed
Location
University of Colorado Cancer Center - Anschutz Cancer Pavilion
Start Date
2010-10
Trial ID
NCT01232829
Treatments Being Tested
This study will determine the maximum tolerated dose, safety and pharmacoki...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00532090
This phase II clinical trial is studying how well giving combination chemot...
Status
Withdrawn
Location
Mayo Clinic
Start Date
2010-12
Trial ID
NCT01270438
This phase I trial studies the side effects and the best dose of gamma-secr...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2010-12
Trial ID
NCT01238133
This partially randomized phase II trial is studying how well giving bicalu...
Status
Terminated
Location
Rutgers Cancer Institute of New Jersey
Start Date
2010-08
Trial ID
NCT01200810
Treatments Being Tested
This phase II trial studies how well RO4929097 works in treating patients w...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-05
Trial ID
NCT01116687
Treatments Being Tested
This randomized phase I trial studies the side effects and best dose of RO4...
Status
Completed
Location
University of Wisconsin Hospital and Clinics
Start Date
2010-09
Trial ID
NCT01218620
This phase I trial is studying the side effects and best dose of RO4929097 ...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2010-11
Trial ID
NCT01208441